Cognex Framtida tillväxt
Future kriterier kontrolleras 2/6
Cognex förväntas öka intäkter och intäkter med 19.2% respektive 8.8% per år. EPS förväntas tillväxt med 19.5% per år. Avkastningen på eget kapital förväntas bli 19.6% om 3 år.
Viktig information
19.2%
Tillväxttakt i vinsten
19.55%
Tillväxttakt för EPS
| Electronic vinsttillväxt | 26.5% |
| Intäkternas tillväxttakt | 8.8% |
| Framtida avkastning på eget kapital | 19.64% |
| Bevakning av analytiker | Good |
| Senast uppdaterad | 11 Aug 2026 |
Senaste uppdateringarna om framtida tillväxt
Recent updates
Seeking Alpha • 18h
Cognex: The Data Center Supply Chain Play The Market Is Underpricing; Strong Buy
Summary Cognex Corporation is poised for durable, margin-accretive growth, driven by expansion into the data center and semiconductor markets. CGNX’s OneVision platform and AI-enabled inspection solutions position it to capture significant upside from the global data center buildout and server refresh cycles. Despite near-term margin headwinds from rising memory costs, I expect robust operating leverage and margin expansion, with an inflection point in eFY27. I reiterate a Strong Buy rating on CGNX with a $95/share price target, viewing current valuation as a modest long-term buying opportunity. Read the full article on Seeking Alpha
Uppdatering av berättelse • Aug 07
CGNX: AI Vision Systems And Margin Expansion Will Support Premium Multiple
Cognex now carries an updated analyst price target framework of $80.42, with recent Street research pointing to higher targets in the $72 to $91 range as analysts factor in AI driven vision systems, end market diversification, and improved margin assumptions. Analyst Commentary Recent Street research on Cognex clusters around a constructive view on AI enabled vision systems, a broader customer base, and scope for better profitability.
Uppdatering av berättelse • Jul 02
CGNX: AI Vision Expansion And End Market Diversification Will Support Fair Outlook
Cognex's updated analyst price framework reflects a modest fair value lift to $64.14 from $61.65, with analysts tying higher targets, often in the $60s to mid $70s range, to AI enabled product progress, broader end market exposure, and more constructive views on revenue growth, margins, and future P/E assumptions. Analyst Commentary Recent Street research on Cognex highlights a mixed but generally constructive tone, with several firms lifting price targets and, in one case, upgrading the stock on the back of AI enabled vision systems, broader end market exposure, and sales model changes.Analysartikel • Jun 20
Cognex (CGNX) Stock Could Be 13.3% Undervalued After Zacks Rank Upgrade
Cognex (CGNX) has moved into focus after being added to the Zacks Rank #1 (Strong Buy) list, a shift driven by a higher consensus earnings estimate for its machine vision business. See our latest analysis for Cognex. Cognex’s recent earnings estimate upgrade and macro driven swings have come against a backdrop of strong share price momentum, with a 90 day share price return of 34.24% and a 1 year total shareholder return of 124.77%. This suggests recent optimism is building on an already...Uppdatering av berättelse • Jun 18
CGNX: AI Vision Expansion And Margin Execution Will Support Premium Stock Multiple
Analysts have raised the implied fair value for Cognex to $76.25 from $65.60, citing higher assumed revenue growth, stronger profit margins, and a series of recent price target increases related to AI-enabled vision systems and an expanding customer base. Analyst Commentary Recent research on Cognex points to a clear split between enthusiasm for the company’s AI-enabled vision systems and a more measured view on how quickly those strengths translate into sustained growth and returns.Uppdatering av berättelse • Jun 03
CGNX: AI Vision Turnaround And Cost Discipline Will Support Fairly Valued Outlook
Narrative Update: Cognex Analyst Price Target Move The analyst price target for Cognex is updated from $50.92 to $61.65, with analysts citing AI-enabled vision systems, a broader customer base, an improved mix, and expense leverage as key factors supporting higher fair value assumptions. Analyst Commentary Recent research updates around Cognex point to a more constructive tone on growth opportunities tied to AI enabled vision systems and a broader customer base, but there is still a pocket of caution that centers on how much of this optimism is already reflected in the stock price and how consistently the company can execute.
Uppdatering av berättelse • May 19
CGNX: Margin Execution And Automation Demand Will Drive Future Share Upside
Analysts have lifted the updated price target framework for Cognex to $90.99 from $60.96, citing broad Street target increases. These changes reflect a more favorable organic growth outlook, stronger gross margin performance, and ongoing operating expense leverage.Analysartikel • May 09
Cognex Corporation Beat Analyst Estimates: See What The Consensus Is Forecasting For This Year
Cognex Corporation ( NASDAQ:CGNX ) just released its quarterly report and things are looking bullish. The company beat...Uppdatering av berättelse • Apr 28
CGNX: Margin Discipline And End Market Recovery Will Support Fairly Valued Outlook
Cognex's analyst price target has slipped slightly from about $52 to $50.92 as analysts balance a softer revenue growth outlook with firmer margin expectations and still elevated P/E assumptions. Analyst Commentary Recent research on Cognex shows a split view, with some firms lifting targets and ratings while others are taking a more restrained stance as they reassess growth, margins, and valuation after the latest earnings updates.Uppdatering av berättelse • Apr 14
CGNX: Margin Execution And Buybacks Will Support Premium Multiple In Recovery
The analyst price target for Cognex has edged up by $0.10 to $65.60 as analysts highlight margin improvement efforts, cost reduction plans, and a recovering demand backdrop across key end markets. Analyst Commentary Recent research signals a generally constructive shift in sentiment on Cognex, with several banks lifting price targets and a few moving ratings higher as they reassess earnings power, margins, and the demand backdrop.Uppdatering av berättelse • Mar 31
CGNX: Margin Discipline And Buybacks Will Support Premium Multiple In Industrial Recovery
Analyst price targets on Cognex have moved higher, with the updated fair value estimate holding at $65.50. Analysts point to margin improvement, cost initiatives, a recovering short cycle industrial group, and steadier segment trends as key supports for the new targets.Uppdatering av berättelse • Mar 17
CGNX: Margin Execution And Buybacks Will Support Premium Multiple In Industrial Recovery
Cognex's analyst fair value estimate has been revised higher from $60.55 to $65.50. Analysts highlight improving short cycle industrial demand, faster margin progress, cost reduction efforts, and a broader customer base, which support higher revenue growth assumptions and a richer future P/E of 44.37x versus 41.32x previously.Uppdatering av berättelse • Mar 02
CGNX: Margin Execution And Demand Stability Will Shape Fairly Valued Outlook
The analyst fair value estimate for Cognex has been raised from $36.62 to $52.00, reflecting higher Street price targets in the $55 to $75 range and analyst expectations for improved margins, cost control, and a more stable demand backdrop across key segments. Analyst Commentary Recent Street research on Cognex clusters around higher price targets and a more constructive stance on margins, cost controls, and demand stability, but the tone is not uniformly bullish.Analysartikel • Feb 19
We Like The Quality Of Cognex's (NASDAQ:CGNX) Earnings
Investors signalled that they were pleased with Cognex Corporation's ( NASDAQ:CGNX ) most recent earnings report. This...Uppdatering av berättelse • Feb 16
CGNX: Cost Discipline And Automation Demand Will Support Margins And Buybacks
Analysts have raised their price target on Cognex by about $11.90 to $60.55, citing updated assumptions around fair value, discount rate, revenue growth, profit margins, and future P/E multiples, which are in line with recent Street target increases from UBS, Barclays, and KeyBanc. Analyst Commentary Recent target changes around Cognex reflect a mix of optimism on long term demand drivers and some caution on execution and timing, with several firms adjusting their models as part of broader industrial technology outlooks for 2026.Uppdatering av berättelse • Feb 02
CGNX: Industrial Tech Tailwinds Will Face Stricter Execution And Margin Expectations
Analysts have trimmed their price target on Cognex to US$54, down US$2, as they refresh assumptions around fair value, discount rate, revenue growth, profit margin, and future P/E in light of updated views on industrial technology demand across data centers, factory and warehouse automation, electronics, test and measurement, and semiconductors. Analyst Commentary Recent research trims the price target on Cognex to US$54, which signals that some expectations around future growth, margins, and valuation are being reset, even as broader industrial technology end markets such as data centers, factory automation, warehouse automation, electronics, test and measurement, and semiconductors are viewed constructively.Uppdatering av berättelse • Jan 19
CGNX: Cost Cuts And Automation Exposure Will Drive Future Share Upside
Analysts have trimmed their average price target for Cognex by about $2 to roughly $54, reflecting updated views on fair value, discount rate, growth, margins and future P/E after recent sector wide adjustments to industrial technology outlooks. Analyst Commentary Recent Street commentary around Cognex centers on small adjustments to fair value assumptions while keeping a generally constructive view on the company and its exposure to industrial technology end markets.Uppdatering av berättelse • Jan 05
CGNX: Cost Discipline And Activist Pressure Will Drive Stronger Margins
Analysts have nudged their price target for Cognex slightly higher, reflecting a modest fair value increase to about $48.65 as they anticipate margin recovery and stronger 2025 EBITDA, supported by continued R&D investment and disciplined cost control. Analyst Commentary Bullish Takeaways Bullish analysts highlight expectations for a strong EBITDA recovery in 2025, supported by top line growth and disciplined expense management, which underpins the higher fair value range.Uppdatering av berättelse • Dec 21
CGNX: EBITDA Recovery And Cost Cuts Will Drive Strong Share Upside
Analysts have raised their price target on Cognex to a range centered around approximately $55, up from the prior mid $30s to low $40s range. They cite expectations for stronger revenue growth, higher profit margins, and a robust EBITDA recovery supported by disciplined expense management and sustained R&D investment.Uppdatering av berättelse • Dec 07
CGNX: Cost Discipline And Activist Pressure Will Drive Stronger Margins And Earnings
Analysts have nudged their average price target on Cognex slightly higher, with recent moves such as a lift to about $45 and a bullish $55 initiation. These changes reflect expectations for a measured recovery in growth and margins, supported by stronger 2025 EBITDA and disciplined cost control.Uppdatering av berättelse • Nov 23
CGNX: Cost Reductions And Expense Discipline Will Drive Earnings Recovery In 2025
The analyst price target for Cognex has increased from $37 to $45. Analysts cite improved profit margins and expectations for stronger EBITDA recovery, driven by disciplined expense management and robust investments in R&D and sales.Uppdatering av berättelse • Nov 06
CGNX: Expense Discipline And Cost Cuts Will Drive Stronger Margins Ahead
The analyst price target for Cognex has increased from $48.25 to $48.90, as analysts note improving margin prospects beyond near-term tariff headwinds. They also anticipate strong EBITDA recovery driven by disciplined expense management and ongoing growth initiatives.Uppdatering av berättelse • Oct 23
Analysts Weigh Cognex Growth Outlook Amid Valuation Changes and Activist Investor Developments
Analysts have increased their fair value estimate for Cognex from $48.00 to $48.25. This change is attributed to improving demand trends and expectations of stronger future EBITDA margins.Uppdatering av berättelse • Oct 09
Cloud And AI Vision Solutions Will Expand Market Reach
The analyst fair value estimate for Cognex has been raised modestly from $47.21 to $48.00 per share. Analysts anticipate improved revenue growth and margin recovery, supported by disciplined cost management and ongoing investment in core strengths.Uppdatering av berättelse • Sep 25
Cloud And AI Vision Solutions Will Expand Market Reach
Analysts have raised their price target for Cognex to $47.21, citing improving end-market demand, stronger than expected operating leverage, and sector-wide optimism on earnings growth. Analyst Commentary Improving demand across most of Cognex's end markets is expected to drive a return to more normalized upcycle operating leverage into 2026.Analysartikel • Sep 21
When Should You Buy Cognex Corporation (NASDAQ:CGNX)?
While Cognex Corporation ( NASDAQ:CGNX ) might not have the largest market cap around , it led the NASDAQGS gainers...Uppdatering av berättelse • Sep 10
Cloud And AI Vision Solutions Will Expand Market Reach
Analysts have trimmed their price target for Cognex to $46.17 as near-term neutrality and only modest improvements outweigh longer-term optimism for margin expansion and demand recovery in 2026. Analyst Commentary Bullish analysts expect improving demand across most end markets to drive a return to normalized upcycle operating leverage by 2026.Analysartikel • Sep 03
A Look At The Intrinsic Value Of Cognex Corporation (NASDAQ:CGNX)
Key Insights Cognex's estimated fair value is US$46.24 based on 2 Stage Free Cash Flow to Equity Current share price of...Prognoser för vinst- och omsättningstillväxt
| Datum | Intäkter | Intäkter | Fritt kassaflöde | Kassaflöde från rörelsen | Genomsnittligt Antal analytiker |
|---|---|---|---|---|---|
| 12/31/2028 | 1,368 | 368 | 373 | 398 | 10 |
| 12/31/2027 | 1,252 | 323 | 345 | 356 | 19 |
| 12/31/2026 | 1,145 | 274 | 283 | 319 | 19 |
| 7/5/2026 | 1,089 | 175 | 268 | 277 | N/A |
| 4/5/2026 | 1,047 | 143 | 241 | 250 | N/A |
| 12/31/2025 | 994 | 114 | 237 | 246 | N/A |
| 9/28/2025 | 972 | 110 | 214 | 222 | N/A |
| 6/29/2025 | 930 | 122 | 180 | 191 | N/A |
| 3/30/2025 | 920 | 118 | 162 | 176 | N/A |
| 12/31/2024 | 915 | 106 | 134 | 149 | N/A |
| 9/29/2024 | 882 | 89 | 92 | 112 | N/A |
| 6/30/2024 | 844 | 78 | 75 | 97 | N/A |
| 3/31/2024 | 847 | 100 | 77 | 99 | N/A |
| 12/31/2023 | 838 | 113 | 90 | 113 | N/A |
| 10/1/2023 | 880 | 157 | 145 | 165 | N/A |
| 7/2/2023 | 893 | 172 | 189 | 207 | N/A |
| 4/2/2023 | 925 | 174 | 201 | 221 | N/A |
| 12/31/2022 | 1,006 | 216 | 224 | 243 | N/A |
| 10/2/2022 | 1,011 | 214 | 212 | 232 | N/A |
| 7/3/2022 | 1,086 | 259 | 193 | 213 | N/A |
| 4/3/2022 | 1,080 | 277 | 247 | 265 | N/A |
| 12/31/2021 | 1,037 | 280 | 299 | 314 | N/A |
| 10/3/2021 | 1,017 | 296 | 328 | 342 | N/A |
| 7/4/2021 | 983 | 304 | 348 | 361 | N/A |
| 4/4/2021 | 883 | 226 | 266 | 279 | N/A |
| 12/31/2020 | 811 | 176 | 229 | 242 | N/A |
| 9/27/2020 | 757 | 187 | 209 | 227 | N/A |
| 6/28/2020 | 689 | 141 | N/A | 209 | N/A |
| 3/29/2020 | 719 | 191 | N/A | 254 | N/A |
| 12/31/2019 | 726 | 204 | N/A | 253 | N/A |
| 9/29/2019 | 749 | 169 | N/A | 257 | N/A |
| 6/30/2019 | 798 | 208 | N/A | 271 | N/A |
| 3/31/2019 | 810 | 215 | N/A | 230 | N/A |
| 12/31/2018 | 806 | 219 | N/A | 223 | N/A |
| 9/30/2018 | 796 | 146 | N/A | 236 | N/A |
| 7/1/2018 | 830 | 168 | N/A | 206 | N/A |
| 4/1/2018 | 797 | 168 | N/A | 231 | N/A |
| 12/31/2017 | 766 | 177 | N/A | 224 | N/A |
| 10/1/2017 | 712 | 243 | N/A | 215 | N/A |
| 7/2/2017 | 594 | 194 | N/A | 223 | N/A |
| 4/2/2017 | 564 | 180 | N/A | 202 | N/A |
| 12/31/2016 | 530 | 144 | N/A | 182 | N/A |
| 10/2/2016 | 489 | 130 | N/A | 151 | N/A |
| 7/3/2016 | 449 | 103 | N/A | 160 | N/A |
| 4/3/2016 | 445 | 103 | N/A | 152 | N/A |
| 12/31/2015 | 451 | 108 | N/A | 128 | N/A |
| 10/4/2015 | 451 | 111 | N/A | 177 | N/A |
Analytiker Framtid Tillväxt Prognoser
Intäkter kontra sparande: CGNX s prognostiserade vinsttillväxt ( 19.2% per år) är över sparkvoten ( 3.7% ).
Resultat vs marknad: CGNX s intäkter ( 19.2% per år) förväntas växa snabbare än marknaden för US ( 17% per år).
Höga tillväxtresultat: CGNX s intäkter förväntas växa, men inte avsevärt.
Intäkt vs marknad: CGNX s intäkter ( 8.8% per år) förväntas växa långsammare än marknaden för US ( 12.9% per år).
Hög tillväxtintäkter: CGNX s intäkter ( 8.8% per år) förväntas växa långsammare än 20% per år.
Tillväxtprognoser för vinst per aktie
Framtida avkastning på eget kapital
Framtida ROE: CGNX s avkastning på eget kapital förväntas bli låg om 3 år ( 19.6 %).
Upptäck tillväxtföretag
Företagsanalys och finansiella data Status
| Uppgifter | Senast uppdaterad (UTC-tid) |
|---|---|
| Analys av företag | 2026/08/12 14:03 |
| Aktiekurs vid dagens slut | 2026/08/12 00:00 |
| Intäkter | 2026/07/05 |
| Årlig intjäning | 2025/12/31 |
Datakällor
Den data som används i vår företagsanalys kommer från S&P Global Market Intelligence LLC. Följande data används i vår analysmodell för att generera denna rapport. Data är normaliserade vilket kan medföra en fördröjning från det att källan är tillgänglig.
| Paket | Uppgifter | Tidsram | Exempel US-källa |
|---|---|---|---|
| Företagets finansiella ställning | 10 år |
| |
| Analytikernas konsensusuppskattningar | +3 år |
|
|
| Marknadspriser | 30 år |
| |
| Ägarskap | 10 år |
| |
| Förvaltning | 10 år |
| |
| Viktiga utvecklingstendenser | 10 år |
|
* Exempel för amerikanska värdepapper, för icke-amerikanska värdepapper används motsvarande regelverk och källor.
Om inget annat anges är all finansiell data baserad på en årsperiod men uppdateras kvartalsvis. Detta kallas data för efterföljande tolv månader (TTM) eller senaste tolv månader (LTM). Lär dig mer om detta.
Analysmodell och snöflinga
Detaljer om analysmodellen som används för att skapa den här rapporten finns på vår Github-sida, vi har också guider om hur du använder våra rapporter och handledningar på Youtube.
Lär dig mer om det team i världsklass som utformade och byggde analysmodellen Simply Wall St.
Industri- och sektormått
Våra bransch- och sektionsmått beräknas var sjätte timme av Simply Wall St, detaljer om vår process finns tillgängliga på Github.
Källor för analytiker
Cognex Corporation bevakas av 36 analytiker. 19 av dessa analytiker lämnade de uppskattningar av intäkter eller resultat som användes som indata till vår rapport. Analytikernas inskickade estimat uppdateras löpande under dagen.
| Analytiker | Institution |
|---|---|
| Robert Mason | Baird |
| Quinn Fredrickson | Baird |
| Guy Hardwick | Barclays |